MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Delcath Systems Total Assets 2011-2026 | DCTH
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Delcath Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124 M | 76.6 M | 38.6 M | 17.9 M | 33.1 M | 34.6 M | 14.2 M | 6.84 M | 8.89 M | 35.2 M | 15.7 M | 23.8 M | 37.1 M | 30.5 M | 35.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 124 M | 6.84 M | 35.5 M |
Quarterly Total Assets Delcath Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124 M | 117 M | 87.3 M | 76.6 M | 31.7 M | 33.9 M | 36.1 M | 38.6 M | 47.6 M | 21 M | 30.6 M | 17.9 M | 20.2 M | 21.1 M | 27.3 M | 33.1 M | 34.4 M | 24.9 M | 32.3 M | 34.6 M | 34.6 M | 34.6 M | 34.6 M | 14.2 M | 14.2 M | 14.2 M | 14.2 M | 6.84 M | 6.84 M | 6.84 M | 6.84 M | 8.89 M | 8.89 M | 8.89 M | 8.89 M | 35.2 M | 35.2 M | 35.2 M | 35.2 M | 15.7 M | 15.7 M | 15.7 M | 15.7 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 37.1 M | 37.1 M | 37.1 M | 37.1 M | 30.5 M | 30.5 M | 30.5 M | 30.5 M | 35.2 M | 35.2 M | 35.2 M | 35.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 124 M | 6.84 M | 30.9 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.66 | -1.35 % | $ 137 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
41.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.62 | 2.34 % | $ 7.27 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 36.85 | -0.49 % | $ 1.14 B | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Smith & Nephew plc
SNN
|
10.4 B | $ 32.36 | -0.28 % | $ 23.8 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
53.8 M | $ 24.66 | - | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.7 | 1.57 % | $ 747 M | USA |
 |
Sensus Healthcare
SRTS
|
53 M | $ 4.1 | -2.84 % | $ 66.9 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.4 M | $ 1.32 | -0.38 % | $ 21.3 M | USA |
 |
Cytosorbents Corporation
CTSO
|
47.4 M | $ 0.57 | -15.09 % | $ 31 M | USA |
 |
Aethlon Medical
AEMD
|
7.36 M | $ 2.3 | -0.86 % | $ 3.59 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Stryker Corporation
SYK
|
47.8 B | $ 329.19 | 0.5 % | $ 126 B | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 63.79 | 0.77 % | $ 3.48 B | Britain |
 |
InspireMD
NSPR
|
69.4 M | $ 1.82 | 3.99 % | $ 117 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 11.41 | 0.13 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
1.83 B | $ 337.09 | 0.24 % | $ 13.1 B | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 4.15 | 1.22 % | $ 613 M | USA |
 |
Tandem Diabetes Care
TNDM
|
881 M | $ 23.86 | -1.65 % | $ 1.62 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
210 M | $ 2.26 | -1.53 % | $ 133 M | Israel |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 16.19 | -0.25 % | $ 380 M | USA |
 |
Myomo
MYO
|
38.6 M | $ 0.73 | 4.77 % | $ 30.6 M | USA |
 |
NanoVibronix
NAOV
|
3.63 M | - | - | $ 1.08 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 51.48 | 0.14 % | $ 1.51 B | USA |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.29 | -0.77 % | $ 52.5 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
Viemed Healthcare
VMD
|
199 M | $ 9.33 | -0.21 % | $ 363 M | USA |